-
Find us easily on Google MapsFind us easily on Google Maps
-
info@oncolinkpharmacy.cominfo@oncolinkpharmacy.com
-
Contact Us +92 327 6170609Contact Us +92 327 6170609

Brand: Stivant
Generic: Bevacizumab
Pack Size: 1 Vial (16ml)
Product Type: Injection
Category: Anti-Cancer
Price: ₨45,000(Contact us for updated pricing and availability)
Important Notice: Stivant 400mg Injection is a prescription-only oncology medicine. It must be prescribed by a qualified oncologist and administered by trained healthcare professionals in a clinical setting. The information on this page is for reference only and does not replace the advice of your treating physician.
Stivant 400mg Injection is a targeted anti-cancer therapy. Its active ingredient, Bevacizumab, is a recombinant humanized monoclonal antibody that belongs to a class of medicines known as angiogenesis inhibitors.
Bevacizumab works by targeting and blocking Vascular Endothelial Growth Factor (VEGF), a protein that signals the body to grow new blood vessels. Tumors depend on newly formed blood vessels to receive oxygen and nutrients that fuel their growth and spread. By inhibiting VEGF, Stivant effectively cuts off the blood supply to tumors, slowing or halting their growth.
Stivant 400mg is the higher-strength vial containing 400mg of Bevacizumab in 16ml of solution for intravenous (IV) infusion. It is used in combination with other chemotherapy regimens under the direct supervision of an oncologist.
Stivant 400mg (Bevacizumab) is approved for use in several cancer types, typically in combination with standard chemotherapy protocols. These include:
Colorectal Cancer: Stivant is used as part of first-line and second-line treatment regimens for metastatic colorectal cancer in combination with fluoropyrimidine-based chemotherapy.
Non-Small Cell Lung Cancer (NSCLC): Used in combination with carboplatin and paclitaxel for patients with unresectable, locally advanced, recurrent, or metastatic non-squamous NSCLC.
Renal Cell Carcinoma (Kidney Cancer): Stivant is prescribed in combination with interferon alfa-2a for patients with advanced or metastatic renal cell carcinoma.
Glioblastoma: Used for adult patients with recurrent glioblastoma (a type of brain cancer), as a standalone therapy or with irinotecan.
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: Bevacizumab is used in advanced epithelial ovarian cancer in combination with carboplatin and paclitaxel, as well as in recurrent settings.
Cervical Cancer: Stivant is approved for persistent, recurrent, or metastatic cervical cancer in combination with paclitaxel and cisplatin or paclitaxel and topotecan.
Stivant 400mg injection is administered intravenously (through a drip into a vein) under the supervision of trained medical or nursing staff in a hospital or oncology clinic. The dosage and frequency of administration depend on:
Typical Bevacizumab dosing schedules range from every 2 to every 3 weeks. The 400mg vial is often selected for patients with higher body weight, where larger doses are required per cycle.
Dosing must be determined exclusively by the treating oncologist. Do not alter the dose or schedule without medical guidance.
As with all prescription oncology medicines, Stivant 400mg may cause side effects. Patients should be closely monitored by their oncologist throughout the course of treatment. Reported side effects include:
Before starting Stivant therapy, patients and caregivers must inform their oncologist of the following:
Surgery: Stivant should be discontinued at least 28 days before elective surgery and not restarted until surgical wounds are fully healed.
Pregnancy and Breastfeeding: Bevacizumab can harm an unborn baby. Women of childbearing age must use effective contraception during treatment and for at least 6 months after the final dose. Breastfeeding should be avoided during treatment.
Hypertension: Pre-existing or treatment-induced high blood pressure requires close monitoring and management.
Prior Bleeding History: Patients with a history of significant bleeding events require careful evaluation before starting Stivant.
Kidney Function: Regular urine tests should be performed to monitor for protein in the urine.
Disclose your complete medical history, all current medications, and any allergies to your oncologist before treatment begins.
At OncoLink Pharmacy, Stivant 400mg Injection is available at competitive pricing. Prices for oncology medicines may vary based on stock levels, manufacturer supply, and applicable regulatory pricing guidelines.
For the most current and confirmed price of Stivant 400mg in Pakistan, please contact OncoLink Pharmacy directly:
OncoLink Pharmacy is Lahore’s dedicated oncology pharmacy, built specifically to serve cancer patients, oncologists, hospitals, and caregivers across Pakistan. Here is why patients and healthcare providers trust us:
Cold-Chain Storage: Bevacizumab is a biological medicine that requires temperature-controlled storage. Our pharmacy maintains cold-chain integrity from storage to delivery to protect the medicine’s efficacy.
Competitive Pricing: We understand the financial burden of cancer treatment. OncoLink Pharmacy works to provide authentic oncology medicines at competitive and transparent prices.
Fast Nationwide Delivery: We deliver Stivant 400mg and other oncology medicines to Lahore, Karachi, Islamabad, Rawalpindi, Faisalabad, Multan, Peshawar, Quetta, and all other major cities of Pakistan.
Specialist Oncology Expertise: Unlike general pharmacies, OncoLink Pharmacy specializes exclusively in oncology, haematology, and rheumatology, meaning our team understands the urgency and clinical sensitivity of cancer treatment medicines.
Dedicated Patient Support: Our support team is available to assist patients and caregivers with medicine availability queries, order placement, and prescription verification. We recognize that patients seeking cancer medicines often do so under time-sensitive circumstances.
Stivant 400mg Injection, manufactured by CCL Oncology, is available in Pakistan through licensed oncology pharmacies. It is a prescription-only medication and cannot be dispensed without a valid prescription from a registered oncologist.
OncoLink Pharmacy maintains a consistent stock of Stivant injections across both strengths, 100mg and 400mg, and can dispatch orders promptly to patients nationwide. For availability confirmation and order placement, contact our pharmacy team via WhatsApp or phone.
The approximate price of Stivant 400mg Injection in Pakistan is around ₨45,000. For the most current price, please contact OncoLink Pharmacy directly at +92 327 6170609.
Yes, Stivant is manufactured by CCL Oncology and is available through licensed oncology pharmacies in Pakistan, including OncoLink Pharmacy. Both the 100mg/4ml and 400mg/16ml vials are stocked.
Yes. Stivant 400mg is a prescription-only oncology medicine. A valid prescription from a registered oncologist is required. This medicine should only be used under medical supervision in a clinical or hospital setting.
Yes. OncoLink Pharmacy offers nationwide delivery for oncology medicines, including Stivant 400mg. We deliver to Lahore, Karachi, Islamabad, Rawalpindi, Faisalabad, Multan, and all major cities across Pakistan.
Both vials contain the same active ingredient, Bevacizumab. The 100mg vial contains 4ml of solution, while the 400mg vial contains 16ml. The appropriate strength is selected by your oncologist based on the prescribed dose for your specific treatment protocol.
| miligrams | 100mg, 400mg |
|---|